Article

Pharmaceutical Executive

Pharmaceutical Executive

Pharmaceutical Executive-05-01-2004
Volume

May 2004 Table of Contents

May 2004 Table of Contents

External Link - article-94607.pdf

Articles in this issue
The Risk Management Mandate
The Risk Management Mandate
Partners in Learning
Partners in Learning
Early Warnings
Early Warnings
May 2004 Table of Contents

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Pharmaceutical Executive
Pharmaceutical Executive
Peter Rubin
Related Content
How Cell and Gene Therapy Developers Can Reduce Risk of FDA Complete Response Letters With Proactive CMC Strategies
October 2nd 2025

How Cell and Gene Therapy Developers Can Reduce Risk of FDA Complete Response Letters With Proactive CMC Strategies

Louis Cicchini, PhD, and Michael Day, PhD
Pharmaceutical Executive
October 2nd 2025

Pharmaceutical Executive Daily: Novo Nordisk Resubmits BLA for Awiqli

Nicholas Jacobus
Stock.adobe.com
October 2nd 2025

Halozyme Enters $750 Million Definitive Agreement with Elektrofi Aiming to Expand Drug Delivery and Bolster Long-Term Growth

Nicholas Jacobus
Pharmaceutical Executive
October 2nd 2025

Pharmaceutical Executive Daily: September 29, 2025

Nicholas Jacobus
President Donald Trump
October 2nd 2025

Pfizer Announces Agreement with Trump Administration to Lower Prices, Join TrumpRx, and Avoid Tariffs

Mike Hollan
Pharmaceutical Executive
October 2nd 2025

Pharmaceutical Executive Daily: TrumpRx Revealed

Nicholas Jacobus
© 2025 MJH Life Sciences

All rights reserved.